Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer

1 Aug 2006

Abstract excerpt

AIM: Recent studies had suggested substantial molecular differences between tumours from different ethnic groups. In this study, the molecular differences between the incidences of colorectal carcinoma in Saudi and Swiss populations are investigated. METHOD: 518 cases of colon cancer tumours (114 from Saudi Arabia and 404 from Switzerland) were analysed in a tissue microarray format. Fluorescence in situ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16882699
DOI: 10.1136/jcp.2006.038281

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerPMID 16882699Read ↗

The Genomic Landscape of Colorectal Cancer in the Saudi Arabian Population Using a Comprehensive Genomic PanelSemantic proximity Read ↗

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.Semantic proximity Read ↗

Full Molecular Screening of Colon Cancer in Patients Inherited Familial/Highly Germline BRCA1 and BRCA2 MutationsSemantic proximity Read ↗

Investigating incidence of RAS/RAF and PIK3CA alterations in HER2-amplified colorectal cancer: a comprehensive analysis.Semantic proximity Read ↗

KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer.Semantic proximity Read ↗

c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal CancerSemantic proximity Read ↗

Tissue microarray analysis of EGFR gene amplification and gain in Bulgarian patients with colorectal cancer.Semantic proximity Read ↗

Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2.Semantic proximity Read ↗

Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution patternSemantic proximity Read ↗

ALK gene amplification is associated with poor prognosis in colorectal carcinomaSemantic proximity Read ↗

RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification.Semantic proximity Read ↗

HER 2/neu expression and gene amplification in colon cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.